Page last updated: 2024-10-26

diphenyleneiodonium and Leukemia

diphenyleneiodonium has been researched along with Leukemia in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arai, Y1
Nakamura, Y1
Inoue, F1
Yamamoto, K1
Saito, K1
Furusawa, S1

Other Studies

1 other study available for diphenyleneiodonium and Leukemia

ArticleYear
Glucocorticoid-induced apoptotic pathways in eosinophils: comparison with glucocorticoid-sensitive leukemia cells.
    International journal of hematology, 2000, Volume: 71, Issue:4

    Topics: Apoptosis; Caspases; Cell Culture Techniques; Dexamethasone; Enzyme Inhibitors; Eosinophils; Glucoco

2000